Kimberly Florentine Perry, MD | |
1231 Cumberland Xing, Valparaiso, IN 46383 | |
(219) 548-3843 | |
(219) 548-3256 |
Full Name | Kimberly Florentine Perry |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 31 Years |
Location | 1231 Cumberland Xing, Valparaiso, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861453565 | NPI | - | NPPES |
000000521635 | Other | IN | ANTHEM |
200104750A | Medicaid | IN | |
5251392 | Other | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 01045170 (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Elara Caring | South bend, IN | Home health agency |
Porter Home Health | Valparaiso, IN | Home health agency |
Northwest Health - Porter | Valparaiso, IN | Hospital |
St Mary Medical Center Inc | Hobart, IN | Hospital |
Franciscan St Anthony Health - Michigan City | Michigan city, IN | Hospital |
Franciscan Health Crown Point | Crown point, IN | Hospital |
Saint Joseph Regional Medical Center - Plymouth | Plymouth, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Porter Physician Services Llc | 1850482407 | 91 |
Rci (wrs), Llc. | 5092624510 | 312 |
News Archive
Veloxis Pharmaceuticals and Athena Drug Delivery Solutions Pvt. Ltd. today announced an alliance whereby Athena will obtain exclusive rights in certain emerging market territories to manufacture and, with third parties, develop, register and commercialize Veloxis' AtorFen (Fenofibrate Atorvastatin fixed dose combination).
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
'Branching Out' is a new project led by Loughborough University that aims to develop new ways of mapping, predicting, and communicating the social and cultural values of trees so local authorities can make robust, evidence-based decisions around urban treescapes.
A flexible, biodegradable optical fiber that can deliver light into the body for medical applications is the latest work of a collaboration between electrical engineers and biomaterials engineers in Penn State's Materials Research Institute.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
› Verified 3 days ago
Entity Name | Porter Physician Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508075680 PECOS PAC ID: 1850482407 Enrollment ID: O20070810000409 |
News Archive
Veloxis Pharmaceuticals and Athena Drug Delivery Solutions Pvt. Ltd. today announced an alliance whereby Athena will obtain exclusive rights in certain emerging market territories to manufacture and, with third parties, develop, register and commercialize Veloxis' AtorFen (Fenofibrate Atorvastatin fixed dose combination).
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
'Branching Out' is a new project led by Loughborough University that aims to develop new ways of mapping, predicting, and communicating the social and cultural values of trees so local authorities can make robust, evidence-based decisions around urban treescapes.
A flexible, biodegradable optical fiber that can deliver light into the body for medical applications is the latest work of a collaboration between electrical engineers and biomaterials engineers in Penn State's Materials Research Institute.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kimberly Florentine Perry, MD 2022 Kelle Dr, Chesterton, IN 46304-8708 Ph: (219) 364-3616 | Kimberly Florentine Perry, MD 1231 Cumberland Xing, Valparaiso, IN 46383 Ph: (219) 548-3843 |
News Archive
Veloxis Pharmaceuticals and Athena Drug Delivery Solutions Pvt. Ltd. today announced an alliance whereby Athena will obtain exclusive rights in certain emerging market territories to manufacture and, with third parties, develop, register and commercialize Veloxis' AtorFen (Fenofibrate Atorvastatin fixed dose combination).
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
'Branching Out' is a new project led by Loughborough University that aims to develop new ways of mapping, predicting, and communicating the social and cultural values of trees so local authorities can make robust, evidence-based decisions around urban treescapes.
A flexible, biodegradable optical fiber that can deliver light into the body for medical applications is the latest work of a collaboration between electrical engineers and biomaterials engineers in Penn State's Materials Research Institute.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
› Verified 3 days ago
Dr. Mazen Zaitoon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 East United States 6 Frontage, Valparaiso, IN 46383 Phone: 219-983-8300 | |
Douglas Adolph Mazurek, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 Glendale Blvd, Suite 103, Valparaiso, IN 46383 Phone: 219-464-9054 Fax: 219-465-1749 | |
Michael Christopher Hansen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6, Valparaiso, IN 46383 Phone: 219-464-9054 Fax: 219-465-1749 | |
John Dougherty, Internal Medicine Medicare: Medicare Enrolled Practice Location: 56 Willow St, Valparaiso, IN 46383 Phone: 219-309-7254 | |
Dr. Akshay R. Trivedi, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2206 Roosevelt Rd Ste A, Valparaiso, IN 46383 Phone: 219-464-2285 | |
George E Sloan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Roosevelt Rd, Valparaiso, IN 46383 Phone: 219-464-1620 Fax: 219-477-4565 | |
Dr. Jay Shah, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6 Ste 300, Valparaiso, IN 46383 Phone: 219-983-6300 Fax: 219-263-7620 |